Biobot Surgical

The Mona Lisa surgical robot. [Image courtesy of Biobot Surgical]Biobot Surgical announced today that it closed a Series B funding round worth $18 million to support its surgical robot.

Tony Tan, a healthcare entrepreneur, led the round for the robotic-assisted transperineal biopsy and treatment company. Existing shareholder Zig Ventures also participated. Biobot plans to use the funds raised to accelerate its global expansion and commercial footprint.

CEO Albert Lee wrote a letter to shareholders announcing the closing of the round. He said the funding “marks a significant milestone” in the company’s journey toward transforming the field of transperineal biopsy and treatment.

“With the FDA clearance of our groundbreaking surgical robotic system, Mona Lisa 2.0, we are well-positioned to achieve this goal,” Lee wrote.

More about the Biobot Mona Lisa robot

Biobot designed Mona Lisa as a robotic-assisted transperineal needl…